Philips invests in Common Sensing’s smart cap system Patients with conditions such as diabetes depend on regular injections to stay healthy. But because they give the shots themselves, there’s usually no way for their providers to know if they’re using the medication correctly. Common Sensing — based in Cambridge, Massachusetts — has a solution. The company’s Gocap system uses a smart cap that records dosage, timing and storage information of injectable medication, including insulin, fertility medications, growth hormones and others. Gocap can also share this data in real time to doctors, so they can make sure patients are getting the dosage they need. Philips sees huge potential in the company and has contributed to the company’s $6.6 million USD Series A financing round.
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.